摘要:
The invention discloses a system, method and medical device for measuring various hemoglobin derivatives, such as oxyhemoglobin, reduced hemoglobin, partial hemoglobin, carboxyhemoglobin, methemoglobin and sulfhemoglobin in whole or in hemolyzed blood. The novel method uses a statistical approach to enable the design of a portable co-oximeter. This portable co-oximeter utilizes compact light sources, such as light emitting diodes or light emitting lasers, to emit light in the visible region. Being portable, the device is a point-of-care device that can be used in emergency situations by paramedics, in the emergency room, and in a physicians office to detect and measure the concentrations and/or percentages of functional and non-functional hemoglobin derivatives in a patient's blood.
摘要:
An electronic sensor is described that includes a sample receptacle and a data storage device. The data storage device is powered by a pair of half cells on the sensor. The half cells contain ion solutions that are also used to calibrate the sensor. As the sensor is placed within a sensor data reader, the data stored on the data storage device is transferred to the reader along with measurements of the voltage potential between the half cells. The reader thereafter calculates a calibration slope curve for the sensor. The calibration slope curve is then used to determine the exact ion concentration of any sample that is placed in the sample receptacle.
摘要:
A method and means for determining the risk of future cardiac ischemic events in a patient after a sentinel event in that same patient, wherein levels of acid glycoprotein and CK-MB are monitored relative to predetermined threshold levels, within a prescribed time frame after the sentinel event, and these monitored levels are then correlated with the predicted likelihood of future cardiac ischemic events to classify such cardiac patients into categories of risk.
摘要:
The invention disclosed provides a method for preparing spherical-like encapsulated aminoglycosides which may be administered orally to a patient, and which retain antibacterial properties without significant degradation stomachically. The present invention also provides spherical-like encapsulated aminoglycosides and a method for introducing aminoglycosides into a patient by oral ingestion without significant degradation of bactericidal properties.